Shares of Synta Pharmaceuticals Corp. (NASDAQ:MDGL) gapped up prior to trading on Monday . The stock had previously closed at $9.38, but opened at $9.41. Synta Pharmaceuticals Corp. shares last traded at $10.05, with a volume of 17,679 shares changing hands.

The firm’s 50 day moving average is $8.72 and its 200-day moving average is $10.19.

Madrigal Pharmaceuticals, Inc, formerly Synta Pharmaceuticals Corp., is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The Company’s lead product, MGL-3196, is a Phase II-ready once-daily, oral, liver-directed selective thyroid hormone receptor-b (THR-b) agonist for the treatment of NASH, and heterozygous and homozygous familial hypercholesterolemia (FH).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.